What should a marketing leader verify before pursuing a CMO job in India?

Ask where growth has slowed, which customer behaviour must change and what evidence rules out product, pricing, distribution or sales execution as the primary constraint. The purpose is to locate marketing within the commercial system. Treat that distinction as the first gate. Keep contrary evidence with its source. Do not let interview momentum settle it.

Create a growth-ownership map linking customer behaviour to the functions that can influence it. Assign the CMO only the outcomes supported by clear decisions over proposition, investment, channel and measurement. Revenue accountability without influence over the controlling commercial variables is an aspiration, not a defensible executive mandate.

A CMO mandate may be asked to solve slowing volume, weak pricing, poor retention, channel conflict, brand erosion or an undifferentiated product. The contradiction appears when all growth shortfalls are assigned to marketing even though the decisive lever sits in product, distribution or sales execution. Ask which customer behaviour must change, which economic measure will demonstrate it and which other function owns a necessary part of the result. Review cohort or household evidence, channel performance, pricing history and one recent growth decision. Compare the CEO's diagnosis with those of sales and product leaders. The consequence is whether marketing can form a tractable demand system or becomes the narrative owner for an enterprise problem. Stop if sponsors cannot isolate the behaviour marketing may influence, if success measures remain only revenue or awareness, or if the company expects the CMO to accept a growth target while preserving the product, channel and commercial choices that determine whether demand can convert.

Test how the company distinguishes brand, performance, distribution and sales effects; how research informs portfolio decisions; and whether customer data definitions are shared. Ask what leaders do when evidence remains ambiguous. Turn the gap into an authority question. Ask for one contested decision. Record who resolved it and how.

Select one recent investment decision and trace the hypothesis, measurement window, counterfactual and action taken. Look for disciplined learning rather than false precision or retrospective justification. No interview process can validate marketing effectiveness from headline metrics; underlying definitions, controls and decision use require authorised review.

Customer-centric language can conceal fragmented research, disputed attribution and budgets assigned before evidence is reviewed. The contradiction is a mandate to create demand without a credible view of customers or investment response. Trace one campaign or proposition from insight through allocation, activation, sales outcome and learning. Request the research source, measurement design, agency and media economics, and the reconciliation between marketing and commercial reporting. Ask finance or analytics to challenge the interpretation. The executive consequence is whether the CMO can shift resources based on evidence or must defend inherited spending with weak causal claims. Perfect attribution is unnecessary, but uncertainty should be explicit and decision thresholds agreed. Stop if source data cannot be inspected, if measures change with performance, or if the organisation expects immediate efficiency commitments before the candidate can distinguish brand, channel, price and product effects in the historical record.

Ask how priorities are settled when sales seeks near-term conversion, product seeks roadmap focus and marketing seeks category investment. Examine whether shared outcomes have one accountable integrator or become recurring consensus negotiations. Test the commitment under visible pressure. Record who accepts the cost. Name who can reverse the choice.

Use a launch scenario to map decision rights before, during and after market entry. Confirm who can change the proposition, reallocate spend and stop an underperforming approach. Collaborative language does not resolve structural conflict when functions hold incompatible measures and no executive forum owns the whole customer outcome.

Marketing, sales and product often agree on growth goals while holding incompatible rights over customer promise, price, road map, lead quality and channel investment. The contradiction produces shared accountability with no resolution mechanism. Select a recent launch or growth miss and identify who framed the segment, set the proposition, chose pricing, committed sales capacity and decided what changed afterward. Review operating charters, launch retrospectives and investment forums. The CMO consequence is whether customer evidence can shape enterprise choices early or is used only to explain results. Collaboration language is not enough when one function can make irreversible commitments for the others. Stop if role boundaries are defined only by relationships, if disputes return to the CEO without criteria, or if marketing is expected to own customer outcomes while sales and product may reject the evidence, timing or investment changes required to improve them.

Explore how the company reacts to a missed quarter, a competitor promotion or a board request for immediate efficiency. Ask which investments are strategic commitments and which remain experiments with explicit continuation rules. Price the uncertainty before it compounds. Separate verified conditions from working assumptions. Give each gap an accountable source.

Propose a portfolio divided into protect, prove and stop categories, each with a different evidence horizon. Test whether sponsors can tolerate honest uncertainty while still demanding disciplined capital choices. A large budget is not evidence of sponsorship when it can be redirected without reference to the agreed customer or brand thesis.

CEOs can support brand building until a difficult quarter converts every marketing choice into a short-term lead-generation demand. The contradiction is a growth ambition whose investment horizon disappears under pressure. Ask sponsors to apply their thesis to a realistic downturn, competitive response or delayed product launch. Review prior budget reallocations, board expectations and how the company distinguished long-term assets from near-term activity. The executive consequence is whether the CMO can manage a portfolio of demand effects or will be measured on a horizon the enterprise repeatedly interrupts. Flexibility is responsible, but unplanned reversals destroy learning and make accountability arbitrary. Agree protected tests, review dates and the conditions for reallocating spend. Stop if no sponsor will own the investment logic, if budget can be removed without revising outcomes, or if brand ambition is used in recruitment while every operating precedent rewards only immediate volume regardless of margin, retention or proposition health.

Warning signs include attribution certainty used as a political weapon, repeated redefinition of growth ownership and brand ambition unsupported by product or service experience. A communications-heavy remit may also be inconsistent with a promised commercial mandate. Write the threshold before final-stage momentum. Reopen only on authorised evidence. Keep reassurance outside the proof record.

Write decision-rights and evidence conditions into the opportunity scorecard. Stop if sponsors will discuss creative ambition but avoid the operating choices, trade-offs and time horizons that make the mandate executable. The decision concerns fit and mandate integrity; it does not predict brand performance or evaluate any employer’s current marketing leadership.

A CMO process warrants a no when the role carries enterprise growth accountability but lacks access to customer evidence, product choices, channel economics or a durable investment compact. Keep a mandate record covering the target behaviour, economic measure, cross-functional rights, data access and budget horizon. Require a current example for each claimed mechanism. The executive consequence of accepting gaps is that the CMO may become the visible owner of growth while other leaders retain the choices that create it. A high-profile brand and large spend do not establish influence. Stop if customer data remains inaccessible, if sales and product rights are deliberately vague, if targets stay fixed while investment assumptions change, or if the company seeks a celebrated marketer to validate a growth story without permitting the independent diagnosis and enterprise trade-offs necessary to make that story credible.